According to BioIntel360, Middle East and Africa diabetes devices market size is expected to record a CAGR of 6.2% during 2023-2027 to reach US$7,355.3 million by 2027, increasing from US$5,453.5 mill...
According to BioIntel360, Middle East and Africa diabetes devices market size is expected to record a CAGR of 6.2% during 2023-2027 to reach US$7,355.3 million by 2027, increasing from US$5,453.5 million in 2023. Over the last five years, the sector has recorded a CAGR of 6.8% to reach US$5,108.0 million in 2022. This offering from BioIntel360 is a bundled offering, combining 4 countries and a key report covering Middle East and Africa region. This report provides an in-depth data-centric analysis of the emerging opportunities in the diabetes devices and therapeutics industry. It covers a detailed view of market size and forecast across various segments such as by category, diagnosis and monitoring devices, therapeutics, route of administration, type of diabetes, distribution channels, and end users. This title from BioIntel360 is a bundled offering, combining the following 5 reports, covering 160+ tables and 212+ figures: Country Report 1 – Middle East and Africa Diabetes Devices and Therapeutics Business Opportunities Databook – Q2 2023 Update Country Report 2 – Israel Diabetes Devices and Therapeutics Business Opportunities Databook – Q2 2023 Update Country Report 3 – South Africa Diabetes Devices and Therapeutics Business Opportunities Databook – Q2 2023 Update Country Report 4 – Saudi Arabia Diabetes Devices and Therapeutics Business Opportunities Databook – Q2 2023 Update Country Report 5 – Turkey Diabetes Devices and Therapeutics Business Opportunities Databook – Q2 2023 Update
This report provides an in-depth, data-centric analysis of the Middle East & Africa diabetes devices and therapeutics market 2018-2027. Below is a summary of key market segments: Diabetes Devices and Therapeutics Market Share by Category • Diagnosis and Monitoring Devices • Therapeutics Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices • Blood Glucose Monitoring Devices • Insulin Delivery Devices • Diabetes Management and Mobile Applications • Artificial Pancreas Devices Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices • Self-Monitoring Blood Glucose Devices • Continuous Blood Glucose Monitoring Devices • Test Strips • Lancets Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices • Insulin Pumps • Insulin Pens • Insulin Syringes Diabetes Devices and Therapeutics Market Share by Therapeutics • Oral Anti-Diabetic Drugs • Insulin • Non-Insulin Injectable Drugs • Combination Drugs Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs • Alpha-Glucosidase Inhibitors • DPP-4 Inhibitors • SGLT-2 Inhibitors Diabetes Devices and Therapeutics Market Share by Insulin • Basal or Long-Acting • Bolus or Fast-Acting • Traditional Human Insulin Drugs • Insulin Biosimilars Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs • GLP-1 Receptor Agonists • Amylin Analogue Diabetes Devices and Therapeutics Market Share by Combination Drugs • Combination Insulin • Oral Combination Diabetes Devices and Therapeutics Market Share by Route of Administration • Subcutaneous • Intravenous • Others Diabetes Devices and Therapeutics Market Share by Type of Diabetes • Type 1 Diabetes • Type 2 Diabetes Diabetes Devices and Therapeutics Market Share by Distribution Channels • Online Pharmacies • Hospital Pharmacies • Retail Pharmacies Diabetes Devices and Therapeutics Market Share by End User • Hospitals • Diabetes Clinics • Homecare
• In-depth understanding of diabetes devices and therapeutics market dynamics: Understand market opportunity, industry dynamics, key trends, and drivers across different market segments and sub-segments of the industry in Middle East & Africa. • Develop market-specific strategies: Identify growth segments and target specific opportunities to formulate your investment strategy; assess market-specific key trends, drivers, and risks in the industry. • Get market share analysis by end users: Get a detailed analysis across different end users such as hospitals, diabetes clinics, and homecare within the Middle East & Africa.
This title from BioIntel360 is a bundled offering, combining the following 5 reports, covering 160+ tables and 212+ figures: Country Report 1 – Middle East and Africa Diabetes Devices and Therapeutics Business Opportunities Databook – Q2 2023 Update Country Report 2 – Israel Diabetes Devices and Therapeutics Business Opportunities Databook – Q2 2023 Update Country Report 3 – South Africa Diabetes Devices and Therapeutics Business Opportunities Databook – Q2 2023 Update Country Report 4 – Saudi Arabia Diabetes Devices and Therapeutics Business Opportunities Databook – Q2 2023 Update Country Report 5 – Turkey Diabetes Devices and Therapeutics Business Opportunities Databook – Q2 2023 Update 1 About this Report 1.1 Research Methodology 1.2 Disclaimer 2 Diabetes Devices and Therapeutics Market Size and Forecast, 2018-2027 3 Diabetes Devices and Therapeutics Market Share by Category, 2018-2027 3.1 Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, 2018-2027 3.2 Diabetes Devices and Therapeutics Market Size by Therapeutics, 2018-2027 4 Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices, 2018-2027 4.1 Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, 2018-2027 4.2 Diabetes Devices and Therapeutics Market Size by Insulin Delivery Devices, 2018-2027 4.3 Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, 2018-2027 4.4 Diabetes Devices and Therapeutics Market Size by Artificial Pancreas Devices, 2018-2027 5 Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices, 2018-2027 5.1 Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, 2018-2027 5.2 Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, 2018-2027 5.3 Diabetes Devices and Therapeutics Market Size by Test Strips, 2018-2027 5.4 Diabetes Devices and Therapeutics Market Size by Lancets, 2018-2027 6 Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices, 2018-2027 6.1 Diabetes Devices and Therapeutics Market Size by Insulin Pumps, 2018-2027 6.2 Diabetes Devices and Therapeutics Market Size by Insulin Pens, 2018-2027 6.3 Diabetes Devices and Therapeutics Market Size by Insulin Syringes, 2018-2027 7 Diabetes Devices and Therapeutics Market Share by Therapeutics, 2018-2027 7.1 Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, 2018-2027 7.2 Diabetes Devices and Therapeutics Market Size by Insulin, 2018-2027 7.3 Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, 2018-2027 7.4 Diabetes Devices and Therapeutics Market Size by Combination Drugs, 2018-2027 8 Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs, 2018-2027 8.1 Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors, 2018-2027 8.2 Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors, 2018-2027 8.3 Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors, 2018-2027 9 Diabetes Devices and Therapeutics Market Share by Insulin, 2018-2027 9.1 Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, 2018-2027 9.2 Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, 2018-2027 9.3 Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, 2018-2027 9.4 Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, 2018-2027 10 Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs, 2018-2027 10.1 Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, 2018-2027 10.2 Diabetes Devices and Therapeutics Market Size by Amylin Analogue, 2018-2027 11 Diabetes Devices and Therapeutics Market Share by Combination Drugs, 2018-2027 11.1 Diabetes Devices and Therapeutics Market Size by Combination Insulin, 2018-2027 11.2 Diabetes Devices and Therapeutics Market Size by Oral Combination, 2018-2027 12 Diabetes Devices and Therapeutics Market Share by Route of Administration, 2018-2027 12.1 Diabetes Devices and Therapeutics Market Size by Subcutaneous, 2018-2027 12.2 Diabetes Devices and Therapeutics Market Size by Intravenous, 2018-2027 12.3 Diabetes Devices and Therapeutics Market Size by Others, 2018-2027 13 Diabetes Devices and Therapeutics Market Share by Type of Diabetes, 2018-2027 13.1 Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, 2018-2027 13.2 Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, 2018-2027 14 Diabetes Devices and Therapeutics Market Share by Distribution Channels, 2018-2027 14.1 Diabetes Devices and Therapeutics Market Size by Online Pharmacies, 2018-2027 14.2 Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, 2018-2027 14.3 Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, 2018-2027 15 Diabetes Devices and Therapeutics Market Share by End User, 2018-2027 15.1 Diabetes Devices and Therapeutics Market Size by Hospitals, 2018-2027 15.2 Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, 2018-2027 15.3 Diabetes Devices and Therapeutics Market Size by Homecare, 2018-2027 16 Further Reading 16.1 About BioIntel360 16.2 Related Research 16.3 Consulting
Table 1: Diabetes Devices and Therapeutics Market Size by Value (USD MM) 2018-2027 Table 2: Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, by Value (USD MM), 2018-2027 Table 3: Diabetes Devices and Therapeutics Market Size by Therapeutics, by Value (USD MM) 2018-2027 Table 4: Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, by Value (USD MM) 2018-2027 Table 5: Diabetes Devices and Therapeutics Market Size by Insulin Delivery Devices, by Value (USD MM) 2018-2027 Table 6: Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, by Value (USD MM) 2018-2027 Table 7: Diabetes Devices and Therapeutics Market Size by Artificial Pancreas Devices, by Value (USD MM) 2018-2027 Table 8: Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, by Value (USD MM) 2018-2027 Table 9: Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, by Value (USD MM) 2018-2027 Table 10: Diabetes Devices and Therapeutics Market Size by Test Strips, by Value (USD MM) 2018-2027 Table 11: Diabetes Devices and Therapeutics Market Size by Lancets, by Value (USD MM) 2018-2027 Table 12: Diabetes Devices and Therapeutics Market Size by Insulin Pumps, by Value (UDS MM) 2018-2027 Table 13: Diabetes Devices and Therapeutics Market Size by Insulin Pens, by Value (UDS MM) 2018-2027 Table 14: Diabetes Devices and Therapeutics Market Size by Insulin Syringes, by Value (UDS MM) 2018-2027 Table 15: Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, by Value (USD MM), 2018-2027 Table 16: Diabetes Devices and Therapeutics Market Size by Insulin, by Value (USD MM), 2018-2027 Table 17: Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, by Value (USD MM), 2018-2027 Table 18: Diabetes Devices and Therapeutics Market Size by Combination Drugs, by Value (USD MM), 2018-2027 Table 19: Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors (USD MM), 2018-2027 Table 20: Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors (USD MM), 2018-2027 Table 21: Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors (USD MM), 2018-2027 Table 22: Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, by Value (USD MM), 2018-2027 Table 23: Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, by Value (USD MM), 2018-2027 Table 24: Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, by Value (USD MM), 2018-2027 Table 25: Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, by Value (USD MM), 2018-2027 Table 26: Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, by Value (USD MM), 2018-2027 Table 27: Diabetes Devices and Therapeutics Market Size by Amylin Analogue, by Value (USD MM), 2018-2027 Table 28: Diabetes Devices and Therapeutics Market Size by Combination Insulin, by Value (USD MM), 2018-2027 Table 29: Diabetes Devices and Therapeutics Market Size by Oral Combination, by Value (USD MM), 2018-2027 Table 30: Diabetes Devices and Therapeutics Market Size by Subcutaneous, by Value (USD MM), 2018-2027 Table 31: Diabetes Devices and Therapeutics Market Size by Intravenous, by Value (USD MM), 2018-2027 Table 32: Diabetes Devices and Therapeutics Market Size by Others, by Value (USD MM), 2018-2027 Table 33: Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, by Value (USD MM), 2018-2027 Table 34: Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, by Value (USD MM), 2018-2027 Table 35: Diabetes Devices and Therapeutics Market Size by Online Pharmacies, by Value (USD MM), 2018-2027 Table 36: Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, by Value (USD MM), 2018-2027 Table 37: Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, by Value (USD MM), 2018-2027 Table 38: Diabetes Devices and Therapeutics Market Size by Hospitals, by Value (USD MM), 2018-2027 Table 39: Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, by Value (USD MM), 2018-2027 Table 40: Diabetes Devices and Therapeutics Market Size by Homecare, by Value (USD MM), 2018-2027
Figure 1: Diabetes Devices and Therapeutics Market Size by Value (USD MM) 2018-2027 Figure 2: Diabetes Devices and Therapeutics Market Share by Category (%), 2018-2027 Figure 3: Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, by Value (USD MM), 2018-2027 Figure 4: Diabetes Devices and Therapeutics Market Size by Therapeutics, by Value (USD MM) 2018-2027 Figure 5: Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices (%), 2018-2027 Figure 6: Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, by Value (USD MM) 2018-2027 Figure 7: Diabetes Devices and Therapeutics Market Size, by Insulin Delivery Devices, by Value (USD MM) 2018-2027 Figure 8: Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, by Value (USD MM) 2018-2027 Figure 9: Diabetes Devices and Therapeutics Market Size, by Artificial Pancreas Devices, by Value (USD MM) 2018-2027 Figure 10: Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices (%), 2018-2027 Figure 11: Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, by Value (USD MM) 2018-2027 Figure 12: Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, by Value (USD MM) 2018-2027 Figure 13: Diabetes Devices and Therapeutics Market Size by Test Strips, by Value (USD MM) 2018-2027 Figure 14: Diabetes Devices and Therapeutics Market Size by Lancets, by Value (USD MM) 2018-2027 Figure 15: Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices (%), 2018-2027 Figure 16: Diabetes Devices and Therapeutics Market Share by Insulin Pumps, by Value (UDS MM) 2018-2027 Figure 17: Diabetes Devices and Therapeutics Market Share by Insulin Pens, by Value (UDS MM) 2018-2027 Figure 18: Diabetes Devices and Therapeutics Market Share by Insulin Syringes, by Value (UDS MM) 2018-2027 Figure 19: Diabetes Devices and Therapeutics Market Share by Therapeutics (%), 2018-2027 Figure 20: Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, by Value (USD MM), 2018-2027 Figure 21: Diabetes Devices and Therapeutics Market Size by Insulin, by Value (USD MM), 2018-2027 Figure 22: Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, by Value (USD MM), 2018-2027 Figure 23: Diabetes Devices and Therapeutics Market Size by Combination Drugs, by Value (USD MM), 2018-2027 Figure 24: Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs (%), 2018-2027 Figure 25: Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors (USD MM), 2018-2027 Figure 26: Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors (USD MM), 2018-2027 Figure 27: Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors (USD MM), 2018-2027 Figure 28: Diabetes Devices and Therapeutics Market Share by Insulin (%), 2018-2027 Figure 29: Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, by Value (USD MM), 2018-2027 Figure 30: Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, by Value (USD MM), 2018-2027 Figure 31: Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, by Value (USD MM), 2018-2027 Figure 32: Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, by Value (USD MM), 2018-2027 Figure 33: Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs (%), 2018-2027 Figure 34: Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, by Value (USD MM), 2018-2027 Figure 35: Diabetes Devices and Therapeutics Market Size by Amylin Analogue, by Value (USD MM), 2018-2027 Figure 36: Diabetes Devices and Therapeutics Market Share by Combination Drugs (%), 2018-2027 Figure 37: Diabetes Devices and Therapeutics Market Size by Combination Insulin, by Value (USD MM), 2018-2027 Figure 38: Diabetes Devices and Therapeutics Market Size by Oral Combination, by Value (USD MM), 2018-2027 Figure 39: Diabetes Devices and Therapeutics Market Share by Route of Administration (%), 2018-2027 Figure 40: Diabetes Devices and Therapeutics Market Size by Subcutaneous, by Value (USD MM), 2018-2027 Figure 41: Diabetes Devices and Therapeutics Market Size by Intravenous, by Value (USD MM), 2018-2027 Figure 42: Diabetes Devices and Therapeutics Market Size by Others, by Value (USD MM), 2018-2027 Figure 43: Diabetes Devices and Therapeutics Market Share by Type of Diabetes (%), 2018-2027 Figure 44: Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, by Value (USD MM), 2018-2027 Figure 45: Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, by Value (USD MM), 2018-2027 Figure 46: Diabetes Devices and Therapeutics Market Share by Distribution Channels (%), 2018-2027 Figure 47: Diabetes Devices and Therapeutics Market Size by Online Pharmacies, by Value (USD MM), 2018-2027 Figure 48: Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, by Value (USD MM), 2018-2027 Figure 49: Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, by Value (USD MM), 2018-2027 Figure 50: Diabetes Devices and Therapeutics Market Share by End User (%), 2018-2027 Figure 51: Diabetes Devices and Therapeutics Market Size by Hospitals, by Value (USD MM), 2018-2027 Figure 52: Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, by Value (USD MM), 2018-2027 Figure 53: Diabetes Devices and Therapeutics Market Size by Homecare, by Value (USD MM), 2018-2027
